Dentsply Sirona (NASDAQ: XRAY) reported Q2 EPS of $0.60, $0.01 better than the analyst estimate of $0.59. Revenue for the quarter came in at $1.04 billion versus the consensus estimate of $1.02 billion.

GUIDANCE:

Dentsply Sirona sees FY2018 EPS of $2.00-$2.15, versus the consensus of $2.57.

• Management expects adjusted EPS for 2018 in the range of $2.00 to 2.15 per diluted share, down from our previous estimate of $2.55 to $2.65. 2018 guidance now assumes an approximately 2% constant currency revenue decline for the full year, down from our previous expectation of 2% constant currency revenue growth. The reduction in our 2018 revenue guidance reflects our lowered second half revenue forecast, partially driven by elevated levels of anticipated inventory destocking at our dealer partners. The reduction in our 2018 EPS guidance reflects the lower revenue expectation and increased margin pressure for the remainder of the year.

For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.